CD19 CAR T cells for adults with relapsed or refractory acute lymphoblastic leukaemia

被引：10
|
作者：
Maus, Marcela V. [1 ]
机构：
[1] Massachusetts Gen Hosp, Cellular Immunotherapy Program, Ctr Canc, Charlestown, MA 02129 USA
来源：
LANCET | 2021年 / 398卷 / 10299期
关键词：
B-CELL;
D O I：
10.1016/S0140-6736(21)01289-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：466 / 467
页数：2
相关论文
共 50 条
  • [21] CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study
    Elad Jacoby
    Sara Ghorashian
    Britta Vormoor
    Barbara De Moerloose
    Nicole Bodmer
    Olga Molostova
    Asaf D Yanir
    Jochen Buechner
    Ronit Elhasid
    Bella Bielorai
    Srdan Rogosic
    Marie-Emilie Dourthe
    Michael Maschan
    Claudia Rossig
    Amos Toren
    Arend von Stackelberg
    Franco Locatelli
    Peter Bader
    Martin Zimmermann
    Jean Pierre Bourquin
    Andre Baruchel
    Leukemia, 2022, 36 : 1525 - 1532
  • [22] CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study
    Jacoby, Elad
    Ghorashian, Sara
    Vormoor, Britta
    De Moerloose, Barbara
    Bodmer, Nicole
    Molostova, Olga
    Yanir, Asaf D.
    Buechner, Jochen
    Elhasid, Ronit
    Bielorai, Bella
    Rogosic, Srdan
    Dourthe, Marie-Emilie
    Maschan, Michael
    Rossig, Claudia
    Toren, Amos
    von Stackelberg, Arend
    Locatelli, Franco
    Bader, Peter
    Zimmermann, Martin
    Bourquin, Jean Pierre
    Baruchel, Andre
    LEUKEMIA, 2022, 36 (06) : 1525 - 1532
  • [23] iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphoma
    Shapiro, Roman M.
    Romee, Rizwan
    LANCET, 2025, 405 (10473): : 98 - 99
  • [24] CD4+CD25+CD127low regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia
    Pan, Ying
    Wang, Huiping
    An, Furun
    Wu, Fan
    Tao, Qianshan
    Li, Yingwei
    Ruan, Yanjie
    Zhai, Zhimin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [25] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CART therapy
    An, Lihong
    Lin, Yuehui
    Deng, Biping
    Yin, Zhichao
    Zhao, Defeng
    Ling, Zhuojun
    Wu, Tong
    Zhao, Yongqiang
    Chang, Alex H.
    Tong, Chunrong
    Liu, Shuangyou
    BMC CANCER, 2022, 22 (01)
  • [26] CD19 CAR-T cell therapy for relapsed / refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
    Zhang, Li-Na
    Song, Yongping
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [27] CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
    Li-Na Zhang
    Yongping Song
    Delong Liu
    Journal of Hematology & Oncology, 11
  • [28] Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study
    Khalife, Roy
    Montroy, Joshua
    Grigor, Emma J. M.
    Fergusson, Dean A.
    Atkins, Harold
    Seftel, Matthew
    Presseau, Justin
    Thavorn, Kednapa
    Holt, Robert A.
    Hay, Kevin
    Lalu, Manoj M.
    Kekre, Natasha
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (01) : E14 - E19
  • [29] Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia
    Myers, Regina M.
    Devine, Kaitlin
    Li, Yimei
    Lawrence, Sophie
    Leahy, Allison Barz
    Liu, Hongyan
    Vernau, Lauren
    Callahan, Colleen
    Baniewicz, Diane
    Kadauke, Stephan
    McGuire, Regina
    Wertheim, Gerald B.
    Kulikovskaya, Irina
    Gonzalez, Vanessa E.
    Fraietta, Joseph A.
    DiNofia, Amanda M.
    Hunger, Stephen P.
    Rheingold, Susan R.
    Aplenc, Richard
    June, Carl H.
    Grupp, Stephan A.
    Wray, Lisa
    Maude, Shannon L.
    BLOOD ADVANCES, 2024, 8 (09) : 2182 - 2192
  • [30] CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
    Shaun Cordoba
    Shimobi Onuoha
    Simon Thomas
    Daniela Soriano Pignataro
    Rachael Hough
    Sara Ghorashian
    Ajay Vora
    Denise Bonney
    Paul Veys
    Kanchan Rao
    Giovanna Lucchini
    Robert Chiesa
    Jan Chu
    Liz Clark
    Mei Mei Fung
    Koval Smith
    Carlotta Peticone
    Muhammad Al-Hajj
    Vania Baldan
    Mathieu Ferrari
    Saket Srivastava
    Ram Jha
    Frederick Arce Vargas
    Kevin Duffy
    William Day
    Paul Virgo
    Lucy Wheeler
    Jeremy Hancock
    Farzin Farzaneh
    Sabine Domning
    Yiyun Zhang
    Nushmia Z. Khokhar
    Vijay G. R. Peddareddigari
    Robert Wynn
    Martin Pule
    Persis J. Amrolia
    Nature Medicine, 2021, 27 : 1797 - 1805
12345